Correction of congenital diaphragmatic hernia in utero IV. An early gestational fetal lamb model for pulmonary vascular morphometric analysis*

https://doi.org/10.1016/S0022-3468(85)80022-1Get rights and content

Infants born with congenital diaphragmatic hernia (CDH) often have specific pathologic abnormalities of the pulmonary microcirculation that result in high pulmonary vascular resistance and extrapulmonary right-to-left shunting after birth. In an attempt to make an animal model with similar vascular changes, we creasted CDH in fetal lambs at 60 to 63 days gestation, repaired some at 100 to 113 days gestation, and subsequently performed morphometric analysis of the pulmonary vasculature. Creation of CDH at this early gestational age resulted in a high fetal mortality rate. In the unrepaired CDH lambs, the pulmonary vascular abnormalities were more severe in the left lung. Similar to human CDH, diaphragmatic hernia in the fetal lamb resulted in a decrease in the total size of the pulmonary vascular bed, a decrease in the number of vessels per unit area lung, and increased muscularization of the arterial tree. Fetal surgical repair of CDH restored the pulmonary arterial bed towards normal.

References (28)

  • NguyenL et al.

    The mortality of congenital diaphragmatic hernia: Is total pulmonary mass inadequate, no matter what?

    Ann Surg

    (1983)
  • WienerES

    Congenital posterolateral diaphragmatic hernia: New dimensions in management

    Surgery

    (1982)
  • NaeyeRL et al.

    Unsuspected pulmonary vascular abnormalities associated with diaphragmatic hernia

    Pediatrics

    (1976)
  • HislopA et al.

    Persistent hypoplasia of the lung after repair of congenital diaphragmatic hernia

    Thorax

    (1976)
  • Cited by (0)

    *

    Supported by Grant No AM 29890, HL 24056, and a NRSA from the National Institutes of Health, and the 13th American College of Surgeons Scholarship.

    Presented before the 16th Annual Meeting of the American Pediatric Surgical Association, Kohala Coast, Hawaii, May 1–4, 1985.

    1

    From the Fetal Treatment Program, University of California, San Francisco, and the Department of Pathology and Anesthesia, Children's Hospital Medical Center, Boston.

    View full text